Funding · Company
Dewpoint Therapeutics, Inc.
Boston, MABiotech & Pharma
Dewpoint Therapeutics, Inc. of Boston, MA has disclosed $227M across 2 Form D offerings filed with the SEC between Feb 4, 2022 and Jul 13, 2026.
$227M
Total disclosed
2
Form D offerings
2018
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$77M
Form D · Jul 13, 2026 ↗
Q3 2026
· 1 amendment, first filed Sep 23, 2025
· target $82M
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2018SEC CIK0001828893Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →